Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sulforaphane

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Sulforaphane?

Sulforaphane is an investigational drug.

There have been 27 clinical trials for Sulforaphane. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.

The most common disease conditions in clinical trials are Autistic Disorder, Disease, and Carcinogenesis. The leading clinical trial sponsors are Johns Hopkins University, National Cancer Institute (NCI), and Evgen Pharma.

There are four hundred and seventeen US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Sulforaphane
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac DysfunctionTexas Tech University Health Sciences CenterPhase 1/Phase 2
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light ExposureJohns Hopkins UniversityEarly Phase 1
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer ChemopreventionJohns Hopkins UniversityPhase 2

See all Sulforaphane clinical trials

Clinical Trial Summary for Sulforaphane

Top disease conditions for Sulforaphane
Top clinical trial sponsors for Sulforaphane

See all Sulforaphane clinical trials

US Patents for Sulforaphane

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sulforaphane   Start Trial Antibody drug conjugates Novartis AG (Basel, CH)   Start Trial
Sulforaphane   Start Trial Combined application of isothiocyanate compound and anti-cancer medicine JC (Wuxi) Company, Inc. (Wuxi, Jiangsu, CN)   Start Trial
Sulforaphane   Start Trial Seaweed extracts, unsaturated fatty acids, and methods of treatment University of Florida Research Foundation, Incorporated (Gainesville, FL) Smithsonian Institution (Washington, DC)   Start Trial
Sulforaphane   Start Trial Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sulforaphane

Drugname Country Document Number Estimated Expiration Related US Patent
Sulforaphane Argentina 102649 2034-11-14   Start Trial
Sulforaphane Australia 2015347015 2034-11-14   Start Trial
Sulforaphane Brazil 112017009813 2034-11-14   Start Trial
Sulforaphane Canada 2967188 2034-11-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.